2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Circulation, 2022 - Am Heart Assoc
Aim: The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces
the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 …

2022 ACC/AHA/HFSA guideline for the management of heart failure

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of Cardiac …, 2022 - Elsevier
ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous …

X Guo, R Shen, S Yan, Y Su, L Ma - Cardiovascular diabetology, 2023 - Springer
Abstract Background The triglyceride-glucose (TyG) index, a reliable surrogate indicator of
insulin resistance, is independently associated with coronary artery disease of various …

Early plasmapheresis among patients with hypertriglyceridemia–associated acute pancreatitis

L Cao, Y Chen, S Liu, W Huang, D Wu… - JAMA Network …, 2023 - jamanetwork.com
Importance The incidence of hypertriglyceridemia–associated acute pancreatitis (HTG-AP)
is increasing. Plasmapheresis is theoretically effective in removing triglyceride from plasma …

Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease

R Wang, PW Serruys, C Gao, H Hara… - European heart …, 2022 - academic.oup.com
Aims The aim of this article was to compare rates of all-cause death at 10 years following
coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) in …

Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention

S Tao, L Yu, J Li, Z Xie, L Huang, D Yang, Y Tan… - Cardiovascular …, 2023 - Springer
Abstract Background The triglyceride-glucose (TyG) index has been proposed as a reliable
surrogate marker of insulin resistance and an independent predictor of major adverse …

Ticagrelor: clinical development and future potential

NC Sanderson, WAE Parker… - Reviews in …, 2021 - eprints.whiterose.ac.uk
Platelets participate centrally in atherothrombosis, resulting in vessel occlusion and
ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further …

Myocardial Revascularization Surgery: JACC Historical Breakthroughs in Perspective

MJ Mack, JJ Squiers, BW Lytle, JM DiMaio… - Journal of the American …, 2021 - jacc.org
Coronary artery bypass grafting (CABG) was introduced in the 1960s as the first procedure
for direct coronary artery revascularization and rapidly became one of the most common …

Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study

IC Lega, MA Campitelli, PC Austin, Y Na, A Zahedi… - Diabetologia, 2021 - Springer
Aims/hypothesis More than 25% of older adults (age≥ 75 years) have diabetes and may be
at risk of adverse events related to treatment. The aim of this study was to assess the …